List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.

  1. Autonomous navigation through small, confined spaces

    SBC: Greensight Agronomics, Inc.            Topic: DTRA182002

    GreenSight Agronomics (GSAg) is proposing to develop a man-portable, fully autonomous aerial mapping system to satisfy the goal of the solicitation: quickly and completely mapping a confined space with no human guidance. The vehicle will have a 400 mm frame size to provide an ideal balance between maneuverability, flight time, and payload capacity. We have chosen the Pixhawk platform running ArduP ...

    SBIR Phase I 2019 Department of DefenseDefense Threat Reduction Agency
  2. Materials Engineering of Alkali Halide and Rare Earth Halide Scintillators

    SBC: Radiation Monitoring Devices, Inc.            Topic: DTRA182007

    Scintillators are the major components of radiation detection systems used in identification of Special Nuclear Materials.One of their key properties is the energy resolution (ER) that links directly to isotope identification capabilities.Typically the ER for scintillators varies from 3% (at 662 keV, FWHM) for the best materials to more common 6-7%.At the moment, many detectors use latter material ...

    SBIR Phase I 2019 Department of DefenseDefense Threat Reduction Agency
  3. Innovative Materials Engineering and Growth of a High Performance and Low Cost Scintillator

    SBC: CAPESYM, INC            Topic: DTRA182007

    The goal of this program is to produce radiation detector scintillators with enhanced-medium energy resolution of 2-3%, at costs approaching those of medium energy resolution detectors such as CsI.To achieve this goal, a two pronged approach will be pursued.First, we will employ materials engineering tools to improve the performance of an existing scintillator with superior attributes.Second, an i ...

    SBIR Phase I 2019 Department of DefenseDefense Threat Reduction Agency
  4. Alternative Signature Detectors for Long Range Nuclear Material Identification

    SBC: Radiation Monitoring Devices, Inc.            Topic: DTRA162003

    Increasing the distance for standoff detection of nuclear materials, beyond that capable with direct radiation detection, using alternative signatures, such as the concentration of ionization in the surrounding atmosphere, improves the ability to locate, track and monitor this material.Ionizing radiation generates free elections, ions, and exited states in the nearby atmosphere, even when the sour ...

    SBIR Phase II 2019 Department of DefenseDefense Threat Reduction Agency
  5. CANTEAN: Cave and Narrow Tunnel Exploration and Navigation

    SBC: Scientific Systems Company Inc.            Topic: DTRA182002

    In response to the DTRA182-002 solicitation, we propose CANTEAN: Cave and Narrow Tunnel Exploration and Navigation, a flying system that employs the use of low-SWaP sensors and processors using advanced algorithms for rapid navigation and mapping of unknown, subterranean areas as part of a heterogeneous team.Bio-inspired obstacle avoidance and navigation and the efficient exchange and merging of s ...

    SBIR Phase I 2019 Department of DefenseDefense Threat Reduction Agency
  6. IED neutralization from an airborne platform

    SBC: Imsar LLC            Topic: DTRA182001

    In cooperation with the Joint Improvised-threat Defeat Organization (JIDO) and the U.S. Army, IMSAR LLC demonstrated its radar systems' ability to successfully detect IED emplacements from the RQ-7B Shadow Unmanned Aerial System (UAS). As part of the Armys ShadowSAR program, IMSAR operated and maintained these Synthetic Aperture Radar (SAR) sensors for 4years in support of Operation Enduring Freed ...

    SBIR Phase I 2019 Department of DefenseDefense Threat Reduction Agency
  7. Topic 378: Symptomatic Toxicity Mobile Monitor (SympTMM)

    SBC: Vivonics, Inc.            Topic: NCI

    The goal of this NIH Phase I SBIR proposal is to develop and validate a new method to monitor the symptomatic toxicities and health-related quality of life of cancer patients who are undergoing and have undergone radiation therapy during the course of their treatment. The proposal is built around expertise in mobile application development (Vivonics Inc.) and radiation oncology (Dr. TJ Fitzgerald ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. Topic 378: PRORAD- A Mobile Application for Patient Related Outcomes of Radiotherapy

    SBC: Charles River Analytics, Inc.            Topic: NCI

    Cancer patients receiving radiation therapy experience toxic side effects of the radiation, and sensitivity to radiation is variable across both patients and tumors, and is poorly understood. This Phase I SBIR project aims to design and demonstrate the feasibility of a Patient Reported Outcome mobile application for surveillance of RADiotherapy toxicity (PRORAD) that integrates NIH's Patient Repor ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  9. Topic 375: 18F PET Tracer For Imaging PD-L1 (Moonshot)

    SBC: SIBTECH, INC.            Topic: NCI

    New therapies, designed to enhance anti-tumor immunity are based on the blockade of the checkpoint components, either PD-1 on immune cells or PD-L1 on tumor cells. This strategy, while being spectacularly successful in some patients for some cancers, fails for many other patients. The expression of PD-L1 is highly dynamic and its prevalence within tumors can vary significantly over time. The curre ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  10. Topic 374: Sustained Delivery of PARP Inhibitors for Cancer Chemoprevention

    SBC: TheraNano LLC            Topic: NCI

    Here we propose to study two injectable formulations that provide different delivery routes for Talazoparib, potent PAPR inhibitor: An implant, InCeT-Talazoparib, which can be injected directly in the tumor where it will act as a sustained release depot of Talazoparib over a prolonged period of approximately 30 days. It delivers 100% of the drug to the tumor site with almost no systemic toxicity. ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government